Meningitis B vaccination, without the guesswork
MenB vaccination turns almost entirely on context: age, medical history, the nature of the accommodation, and whether any outbreak advice currently applies to your destination. Group B disease is not covered by the ACWY vaccine, which is a common source of confusion for travellers who assume one certificate covers everything. University halls, dormitory accommodation and close-contact living arrangements are where the discussion usually becomes worthwhile.
A fast-moving infection spread through close contact
Meningococcal group B disease is caused by Neisseria meningitidis group B bacteria. It can lead to meningitis, septicaemia, or both. The illness is uncommon, but it can move quickly, sometimes over hours rather than days.
The bacteria spread through respiratory droplets and close contact. That means risk is higher where people live, sleep or socialise closely together: halls of residence, boarding schools, military accommodation, camps, shared houses and some healthcare or laboratory settings. Casual contact on a short holiday is usually a different level of exposure.
Early symptoms can look frustratingly ordinary: fever, headache, vomiting, muscle aches, drowsiness or a rash that does not fade under pressure. Neck stiffness and light sensitivity may appear, but they are not always there at the start. For travellers, the issue is access. If you are studying abroad, working remotely for months, or staying somewhere medical care is slow to reach, rapid assessment is harder.
What Bexsero does, and what it cannot cover
Bexsero is a meningococcal group B vaccine. It is licensed for active immunisation from 2 months of age and is designed to trigger antibodies against several MenB bacterial components. It does not cover every meningococcal strain, and it is not the same as the MenACWY vaccine used for many travel and pilgrimage requirements.
For adolescents and adults, the course is usually two injections, with at least one month between doses. Children may need a different schedule, and younger children may also need booster dosing depending on age at the first dose and ongoing risk. The vaccine is given as an intramuscular injection, usually into the upper arm for older children and adults.
Book early if you can. Finishing a two-dose course takes time, and leaving it until the week before departure can limit what can be done before you fly. Common side effects include a sore arm, headache, nausea, muscle aches and feeling generally unwell for a day or two. Fever is more common in younger children, especially when vaccines are given together.
Where MenB comes up in travel consultations
MenB vaccination is not automatically recommended because someone is visiting Kenya, India, Bangladesh or South America. Those destinations may raise other vaccine questions, such as hepatitis A, typhoid, rabies, yellow fever or cholera, but MenB is usually considered for a narrower set of circumstances.
It becomes more relevant for students moving into university accommodation overseas, longer stays with close-contact living, outbreak-linked travel, certain occupational risks, or people with higher medical risk, such as asplenia, splenic dysfunction or some complement-related conditions. Business travellers rarely need MenB for a standard hotel-and-office trip. A six-month secondment in shared accommodation is a different conversation.
Plan the course around your dates
Where your plans involve study, work, an extended stay or close-contact accommodation, bring those specifics to the consultation, since they carry more weight than the destination itself. The prescriber can then establish whether MenB has a genuine place in your vaccination plan or whether ACWY alone covers the risk you actually face. Call 01257 676001 or book an appointment online.